ADVANCED LYMPHOMA
Clinical trials for ADVANCED LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LYMPHOMA trials appear
Sign up with your email to follow new studies for ADVANCED LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug TAK-243 targets cancer cells in early safety trial
Disease control Recruiting nowThis early-phase study tests the safety and best dose of TAK-243, a drug that blocks a key enzyme cancer cells need to grow. About 95 adults with advanced solid tumors or lymphoma who have tried other treatments will receive TAK-243. The goal is to find side effects and the right…
Matched conditions: ADVANCED LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:32 UTC
-
New cancer drug AN4005 enters first human tests
Disease control Recruiting nowThis early-phase study tests a new drug called AN4005 in about 31 adults with advanced solid tumors or lymphoma that has not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. Participants will r…
Matched conditions: ADVANCED LYMPHOMA
Phase: PHASE1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:32 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests two experimental drugs, ZEN003694 and entinostat, in people with advanced or treatment-resistant solid tumors, including pancreatic cancer. The goal is to find the safest dose and see if the combination can shrink tumors. About 49 participants will take part in t…
Matched conditions: ADVANCED LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
Cancer care at home: a game changer for patients?
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in a clinic for people with advanced cancers. The goal is to see if home treatment reduces stress, financial burden, and improves the overall experience. About 220 participants will be randomly assigned to receive their t…
Matched conditions: ADVANCED LYMPHOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 03:23 UTC